NASDAQ:AVXL

Anavex Life Sciences Stock Insider Trading

Healthcare > Biotechnology

Buy AVXL

*Your capital is at risk

$2.65

-0.140 (-5.03%)

At Close: Jun 03, 2026

Anavex Life Sciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 54.54. In total, the insiders bought 9.05M and sold 1.56M AVXL shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	54.54
● Buy	9.05M shares
● Sell	1.56M shares
90% Buy Activity Negligible or No Correlation
Buy Signal High Confidence May 04, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 54.54. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (90% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Jan 15, 2025 Buy	Stock Option (Right to Buy) A-Award	Missling Christopher U President And CEO	CEO / President	125 000 Value: $1.07M
Jan 15, 2025 Buy	Stock Option (Right to Buy) A-Award	Missling Christopher U President And CEO	CEO / President	166 666 Value: $1.26M
Dec 19, 2024 Buy	Stock Option (Right to Buy) A-Award	Boenisch Sandra Pfo & Treasurer	Officer	12 500 Value: $67.0K
Dec 19, 2024 Buy	Stock Option (Right to Buy) A-Award	Missling Christopher U President And CEO	CEO / President	125 000 Value: $670.0K
Dec 19, 2024 Buy	Stock Option (Right to Buy) A-Award	Missling Christopher U President And CEO	CEO / President	125 000 Value: $670.0K
Dec 19, 2024 Buy	Stock Option (Right to Buy) A-Award	Boenisch Sandra Pfo & Treasurer	Officer	12 500 Value: $67.0K
Nov 19, 2024 Buy	Stock Option (Right to Buy) A-Award	Missling Christopher U President And CEO	CEO / President	125 000 Value: $1.26M
Nov 19, 2024 Buy	Stock Option (Right to Buy) A-Award	Boenisch Sandra Pfo & Treasurer	Officer	10 000 Value: $100.9K
Nov 19, 2024 Buy	Stock Option (Right to Buy) A-Award	Boenisch Sandra Pfo & Treasurer	Officer	10 000 Value: $100.9K
Nov 19, 2024 Buy	Stock Option (Right to Buy) A-Award	Missling Christopher U President And CEO	CEO / President	125 000 Value: $1.26M
Jun 14, 2024 Buy	Common Stock P-Purchase	Donhauser Peter D.o. Director	Director	2 835 Value: $10.3K
Jun 14, 2024 Buy	Common Stock P-Purchase	Donhauser Peter D.o. Director	Director	2 835 Value: $10.3K
May 15, 2024 Buy	Common Stock P-Purchase	Thomas Steffen Director	Director	5 000 Value: $22.6K
May 15, 2024 Buy	Common Stock P-Purchase	Thomas Steffen Director	Director	5 000 Value: $22.6K
Mar 28, 2024 Buy	Common Stock M-Exempt	Missling Christopher U President And CEO	CEO / President	73 380 Value: $96.9K
Mar 28, 2024 Sell	Common Stock S-Sale	Missling Christopher U President And CEO	CEO / President	73 380 Value: $375.0K
Mar 28, 2024 Buy	Stock Option (Right to Buy) M-Exempt	Missling Christopher U President And CEO	CEO / President	73 380 Value: $96.9K
Mar 28, 2024 Buy	Stock Option (Right to Buy) M-Exempt	Missling Christopher U President And CEO	CEO / President	73 380 Value: $96.9K
Mar 28, 2024 Sell	Common Stock S-Sale	Missling Christopher U President And CEO	CEO / President	73 380 Value: $375.0K
Mar 28, 2024 Buy	Common Stock M-Exempt	Missling Christopher U President And CEO	CEO / President	73 380 Value: $96.9K
Feb 20, 2024 Buy	Stock Option (Right to Buy) A-Award	Donhauser Peter D.o. Director	Director	50 000 Value: $268.0K
Feb 20, 2024 Buy	Stock Option (Right to Buy) A-Award	Thomas Steffen Director	Director	50 000 Value: $268.0K
Feb 20, 2024 Buy	Stock Option (Right to Buy) A-Award	Velden Claus Vander Director	Director	50 000 Value: $268.0K
Feb 20, 2024 Buy	Stock Option (Right to Buy) A-Award	Ma Jiong Director	Director	50 000 Value: $268.0K
Feb 20, 2024 Buy	Stock Option (Right to Buy) A-Award	Skarpelos Athanasios Director	Director	50 000 Value: $268.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ANAVEX LIFE SCIENCES CORP.

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica...

Read Full Profile Here